WHO approves Bavarian Nordic’s mpox vaccine for teenagers
The hands of a patient with skin rashes caused by the mpox virus are pictured at the Vijana Hospital treatment center in Kinshasa, Congo, on August 30, 2024. —Reuters The WHO says it has given a vaccine default for teenagers on October 8. The Danish biotech company is also preparing to conduct a clinical trial. The US federal health agency has approved the Bavarian vaccine for adults. The World Health Organization (WHO) said on Monday it had approved Bavarian Nordic’s mpox vaccine for teenagers aged 12 to 17, an age group considered particularly vulnerable to outbreaks of the disease that
